Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 16, 2024
A phase 1 open label study to assess the human mass balance and metabolite profile of <sup>14</sup>C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants
Michael R Hodges, Eric Ople, Philip Evans, et al.
The British Journal of Radiology
|
September 5, 2017
Clinical applications of textural analysis in non-small cell lung cancer
Iain Phillips, Mazhar Ajaz, Veni Ezhil, et al.
Biopharmaceutics & Drug Disposition
|
June 11, 2011
Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible
Micaela B Reddy, Alyson Connor, Barbara J Brennan, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Novel Gastroretentive Controlled Release Formulations for Once-Daily Administration: Assessment of Clinical Feasibility and Formulation Concept for Raltegravir
Rajesh Krishna, Matthew L Rizk, Patrick J Larson, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
January 17, 2015
Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk
Colin Greaves, Fiona Gillison, Afroditi Stathi, et al.
Archives of Disease in Childhood
|
June 26, 2024
General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)
Claire Scudder, Julia Townson, Jane Bowen-Morris, et al.
Health Technology Assessment (Winchester, England)
|
April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
Simon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
BMC Nephrology
|
December 8, 2020
Safely reducing haemodialysis frequency during the COVID-19 pandemic
Michelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
May Ee Png, Victoria Harris, Jenna Grabey, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Antimicrobial Agents and Chemotherapy
|
July 16, 2024
A phase 1 open label study to assess the human mass balance and metabolite profile of <sup>14</sup>C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants
Michael R Hodges, Eric Ople, Philip Evans, et al.
The British Journal of Radiology
|
September 5, 2017
Clinical applications of textural analysis in non-small cell lung cancer
Iain Phillips, Mazhar Ajaz, Veni Ezhil, et al.
Biopharmaceutics & Drug Disposition
|
June 11, 2011
Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasible
Micaela B Reddy, Alyson Connor, Barbara J Brennan, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Novel Gastroretentive Controlled Release Formulations for Once-Daily Administration: Assessment of Clinical Feasibility and Formulation Concept for Raltegravir
Rajesh Krishna, Matthew L Rizk, Patrick J Larson, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
January 17, 2015
Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk
Colin Greaves, Fiona Gillison, Afroditi Stathi, et al.
Archives of Disease in Childhood
|
June 26, 2024
General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)
Claire Scudder, Julia Townson, Jane Bowen-Morris, et al.
Health Technology Assessment (Winchester, England)
|
April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
Simon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
BMC Nephrology
|
December 8, 2020
Safely reducing haemodialysis frequency during the COVID-19 pandemic
Michelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
May Ee Png, Victoria Harris, Jenna Grabey, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Page
of 8